Form 8-K - Current report:
SEC Accession No. 0001213900-21-045362
Filing Date
2021-08-27
Accepted
2021-08-27 16:30:46
Documents
13
Period of Report
2021-08-23
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea146544-8k_180life.htm   iXBRL 8-K 29920
  Complete submission text file 0001213900-21-045362.txt   256030

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20210823.xsd EX-101.SCH 3789
3 XBRL DEFINITION FILE atnf-20210823_def.xml EX-101.DEF 27748
4 XBRL LABEL FILE atnf-20210823_lab.xml EX-101.LAB 36804
5 XBRL PRESENTATION FILE atnf-20210823_pre.xml EX-101.PRE 26366
6 EXTRACTED XBRL INSTANCE DOCUMENT ea146544-8k_180life_htm.xml XML 5684
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211219295
SIC: 2834 Pharmaceutical Preparations